A novel N7-methylguanosine-associated feature predicts prognosis in gastric cancer
Background Despite substantial advancements in gastric cancer treatment in recent years, our understanding of the disease’s pathophysiology and progression processes remains limited, and the prognosis for gastric cancer patients remains poor. This study investigated potential prognostic indicators based on $ m^{7} $G-associated long non-coding RNA (lncRNA) and its relationship with gastric cancer (STAD). Methods The researchers used RNA-seq and prognostic data from TCGA, employing Cox regression, co-expression network analysis, and multivariate Cox regression to identify relevant lncRNAs. We compiled four $ m^{7} $G-related lncRNAs into a single signature. Results We found it may be used as a prognostic indicator for gastric cancer. The $ m^{7} $G-related lncRNA profile had an area under the curve of 0.710, significantly more diagnostic than clinicopathological markers. The study also found that the TMB and tumor microenvironment were associated with gastric cancer risk, highlighting their signature’s potential utility for personalized treatment and disease monitoring. Conclusions This study provides a novel signature of $ m^{7} $G-related lncRNAs that can be used as a prognostic indicator for gastric cancer and may help guide the development of targeted immunotherapy for the condition..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
The Egyptian journal of medical human genetics - 25(2024), 1 vom: 27. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhao, Shixing [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Clinicopathological characteristics |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s43042-024-00495-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054940214 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054940214 | ||
| 003 | DE-627 | ||
| 005 | 20240228064702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240228s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s43042-024-00495-5 |2 doi | |
| 035 | |a (DE-627)SPR054940214 | ||
| 035 | |a (SPR)s43042-024-00495-5-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhao, Shixing |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel N7-methylguanosine-associated feature predicts prognosis in gastric cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background Despite substantial advancements in gastric cancer treatment in recent years, our understanding of the disease’s pathophysiology and progression processes remains limited, and the prognosis for gastric cancer patients remains poor. This study investigated potential prognostic indicators based on $ m^{7} $G-associated long non-coding RNA (lncRNA) and its relationship with gastric cancer (STAD). Methods The researchers used RNA-seq and prognostic data from TCGA, employing Cox regression, co-expression network analysis, and multivariate Cox regression to identify relevant lncRNAs. We compiled four $ m^{7} $G-related lncRNAs into a single signature. Results We found it may be used as a prognostic indicator for gastric cancer. The $ m^{7} $G-related lncRNA profile had an area under the curve of 0.710, significantly more diagnostic than clinicopathological markers. The study also found that the TMB and tumor microenvironment were associated with gastric cancer risk, highlighting their signature’s potential utility for personalized treatment and disease monitoring. Conclusions This study provides a novel signature of $ m^{7} $G-related lncRNAs that can be used as a prognostic indicator for gastric cancer and may help guide the development of targeted immunotherapy for the condition. | ||
| 650 | 4 | |a m |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a G methylation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Long non-coding RNA |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prognostic signature |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Clinicopathological characteristics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cox regression |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Zhao, Wenbo |4 aut | |
| 700 | 1 | |a Yao, Chunxia |4 aut | |
| 700 | 1 | |a Tian, Yunxiao |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Egyptian journal of medical human genetics |d Cairo : Egyptian Society of Medical Human Genetics, Medical Genetics Center, AinShams University, 2000 |g 25(2024), 1 vom: 27. Feb. |w (DE-627)SPR038848686 |w (DE-600)2515357-2 |x 2090-2441 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2024 |g number:1 |g day:27 |g month:02 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s43042-024-00495-5 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2024 |e 1 |b 27 |c 02 | ||